Patients with operable HER2-positive breast cancer appear to benefit from the addition of pertuzumab to trastuzumab plus chemotherapy

被引：0
|
作者：
Printz, Carrie
机构：
来源：
CANCER | 2020年 / 126卷 / 09期
关键词：
D O I：
10.1002/cncr.32893
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1827 / 1827
页数：1
相关论文
共 50 条
  • [21] Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study
    Emi Noguchi
    Kenji Tamura
    Masaya Hattori
    Jun Horiguchi
    Nobuaki Sato
    Kazumitsu Kanatani
    Kiyoshi Matsunaga
    Hiroji Iwata
    Yasuhiro Fujiwara
    Breast Cancer, 2019, 26 : 39 - 46
  • [22] Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study
    Noguchi, Emi
    Tamura, Kenji
    Hattori, Masaya
    Horiguchi, Jun
    Sato, Nobuaki
    Kanatani, Kazumitsu
    Matsunaga, Kiyoshi
    Iwata, Hiroji
    Fujiwara, Yasuhiro
    BREAST CANCER, 2019, 26 (01) : 39 - 46
  • [23] Handling of anti-HER2 antibodies, trastuzumab and pertuzumab, in patients with HER2-positive breast cancer
    Araki, Kazuhiro
    Ito, Yoshinori
    ANNALS OF ONCOLOGY, 2015, 26 : 48 - 48
  • [24] Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Hirakawa, Kosei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 17 - 26
  • [25] Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Ferraro, Emanuela
    Singh, Jasmeet
    Patil, Sujata
    Razavi, Pedram
    Modi, Shanu
    Chandarlapaty, Sarat
    Barrio, Andrea, V
    Malani, Rachna
    Mellinghoff, Ingo K.
    Boire, Adrienne
    Wen, Hannah Y.
    Brogi, Edi
    Seidman, Andrew D.
    Norton, Larry
    Robson, Mark E.
    Dang, Chau T.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [26] Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Emanuela Ferraro
    Jasmeet Singh
    Sujata Patil
    Pedram Razavi
    Shanu Modi
    Sarat Chandarlapaty
    Andrea V. Barrio
    Rachna Malani
    Ingo K. Mellinghoff
    Adrienne Boire
    Hannah Y. Wen
    Edi Brogi
    Andrew D. Seidman
    Larry Norton
    Mark E. Robson
    Chau T. Dang
    npj Breast Cancer, 8
  • [27] Trastuzumab plus Paclitaxel in HER2-positive Breast Cancer
    不详
    GYNAKOLOGE, 2016, 49 (08): : 558 - 558
  • [28] Addition of Tucatinib to Trastuzumab and Chemotherapy Improves Survival for Patients With Metastatic, HER2-Positive Breast Cancer
    Printz, Carrie
    CANCER, 2020, 126 (10) : 2113 - 2113
  • [29] Pertuzumab in HER2-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1709 - 1716
  • [30] Trastuzumab/Pertuzumab plus Radiochemotherapy for HER2-positive AEG Tumor
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (06): : 520 - +
12345